Stay updated on Favezelimab Combo in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Favezelimab Combo in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Favezelimab Combo in Advanced Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedThe footer now displays ClinicalTrials.gov revision v3.7.2 instead of v3.7.1.SummaryDifference0.0%

- Check13 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1, indicating an incremental site update.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision label updated to v3.7.0, replacing the old v3.6.6 in the page footer. This reflects a new site release without modifying study data or content.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page history now shows a new revision label v3.6.6, replacing the previous v3.6.5, indicating a minor update to the page's revision metadata.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page shows Revision: v3.6.5 instead of Revision: v3.6.4, indicating a deployed update to the site's build/version information. This change does not alter content or navigation.SummaryDifference0.0%

- Check91 days agoChange DetectedThe page's site revision updated to v3.6.4, replacing v3.6.3. This reflects a new interface version for the page.SummaryDifference0.0%

Stay in the know with updates to Favezelimab Combo in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Favezelimab Combo in Advanced Solid Tumors Clinical Trial page.